List of works - Peter Revill

A global scientific strategy to cure hepatitis B

scientific article published on 10 April 2019

A research agenda for curing chronic hepatitis B virus infection.

scientific article published on 6 September 2017

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

scientific article published on 20 July 2022

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

scientific article published on 10 February 2018

Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease.

scientific article published on May 2013

Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).

scientific article published on 15 September 2016

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

scientific article

Characterization of the innate immune signalling pathways in hepatocyte cell lines.

scientific article

Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2.

scientific article published on 17 September 2009

Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients

scientific article

Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease

scientific article published on 27 May 2008

Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen

scientific article

Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro

scientific article published on 21 December 2015

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user

scientific article published in February 2008

Corchorus yellow vein virus, a New World geminivirus from the Old World.

scientific article published on April 2006

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

scientific article published on 17 August 2016

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

scientific article published on September 2008

Does RNA interference provide new hope for control of chronic hepatitis B infection?

scientific article published on January 2009

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

scientific article

Erratum to: Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro.

scientific article published on 4 August 2016

Ethics and hepatitis B cure research.

scientific article published on 14 November 2016

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.

scientific article published on August 2009

Genotypic profiles of hepatitis B in African immigrants and their clinical relevance.

scientific article

Global strategies are required to cure and eliminate HBV infection.

scientific article published on 24 February 2016

HBV Genotypes: Relevance to Natural History, Pathogenesis and Treatment of Chronic Hepatitis B ⬇️

scientific article published on January 1, 2011

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing

scientific article

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients.

scientific article published on 11 October 2017

Hepatitis B Virus Sensitivity to Interferon-α in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.

scientific article published on 23 October 2017

Hepatitis B amongst Immigrants from Myanmar: Genotypes and their Clinical Relevance

scientific article published on 8 September 2017

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.

scientific article published on 28 November 2012

Identification and sequence analysis of potyviruses infecting crops in Vietnam.

scientific article published on 28 September 2007

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

scientific article

Identification of a subgenomic mRNA encoding the capsid protein of mushroom bacilliform virus, a single-stranded RNA mycovirus.

scientific article published in August 1999

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

scientific article

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

scientific article published on 10 August 2016

In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection

scientific article

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease

scientific article published on 04 May 2018

Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood

scientific article published on 27 September 2018

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

scientific article

Molecular characterization of a novel fastidious mycobacterium causing lepromatous lesions of the skin, subcutis, cornea, and conjunctiva of cats living in Victoria, Australia

scientific article

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome

article

Mushroom bacilliform virus RNA: the initiation of translation at the 5' end of the genome and identification of the VPg.

scientific article published on September 1998

New perspectives on the hepatitis B virus life cycle in the human liver.

scientific article published on 22 February 2016

On the evolution and molecular epidemiology of the potyvirus Papaya ringspot virus

scientific article

Overview of hepatitis B viral replication and genetic variability

scientific article published on April 2016

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus

scientific article published on 11 January 2013

Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'.

scientific article published on 24 November 2016

Sequence diversity of South Pacific isolates of Taro bacilliform virus and the development of a PCR-based diagnostic test.

scientific article published in October 2003

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.

scientific article published on June 2016

Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro

scientific article published on January 2009

Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody ⬇️

scientific article published on January 15, 2011

Taro vein chlorosis virus: characterization and variability of a new nucleorhabdovirus.

scientific article

Taxonomy of the order Mononegavirales: update 2017.

scientific article

Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.

scientific article published on 5 October 2015

Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

scientific article published on 9 November 2011

Viral factors and predicting disease outcomes in chronic hepatitis B.

scientific article published on 11 June 2014

List of works by Peter Revill

A global scientific strategy to cure hepatitis B

A research agenda for curing chronic hepatitis B virus infection.

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease.

Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Characterization of the innate immune signalling pathways in hepatocyte cell lines.

Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2.

Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients

Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease

Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen

Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user

Corchorus yellow vein virus, a New World geminivirus from the Old World.

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

Does RNA interference provide new hope for control of chronic hepatitis B infection?

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

Erratum to: Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro.

Ethics and hepatitis B cure research.

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.

Genotypic profiles of hepatitis B in African immigrants and their clinical relevance.

Global strategies are required to cure and eliminate HBV infection.

HBV Genotypes: Relevance to Natural History, Pathogenesis and Treatment of Chronic Hepatitis B ⬇️

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients.

Hepatitis B Virus Sensitivity to Interferon-α in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.

Hepatitis B amongst Immigrants from Myanmar: Genotypes and their Clinical Relevance

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.

Identification and sequence analysis of potyviruses infecting crops in Vietnam.

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

Identification of a subgenomic mRNA encoding the capsid protein of mushroom bacilliform virus, a single-stranded RNA mycovirus.

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease

Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

Molecular characterization of a novel fastidious mycobacterium causing lepromatous lesions of the skin, subcutis, cornea, and conjunctiva of cats living in Victoria, Australia

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome

Mushroom bacilliform virus RNA: the initiation of translation at the 5' end of the genome and identification of the VPg.

New perspectives on the hepatitis B virus life cycle in the human liver.

On the evolution and molecular epidemiology of the potyvirus Papaya ringspot virus

Overview of hepatitis B viral replication and genetic variability

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus

Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'.

Sequence diversity of South Pacific isolates of Taro bacilliform virus and the development of a PCR-based diagnostic test.

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.

Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro

Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody ⬇️

Taro vein chlorosis virus: characterization and variability of a new nucleorhabdovirus.

Taxonomy of the order Mononegavirales: update 2017.

Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.

Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Viral factors and predicting disease outcomes in chronic hepatitis B.